MedPath
HSA Approval

ACTAMONE F.C. TABLET 10 MG

SIN15017P

ACTAMONE F.C. TABLET 10 MG

ACTAMONE F.C. TABLET 10 MG

May 25, 2016

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

R03DC03

montelukast

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Actavis Ltd.

Active Ingredients

Montelukast Sodium 10.40mg equivalent to Montelukast

10.00 mg

Montelukast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACTAMONE F.C. TABLET 10 MG - HSA Approval | MedPath